정신병적 증상을 동반한 알츠하이머병에서 앞쪽뇌량 부피의 감소: 자기공명영상 단면연구 = Reduced Volume of Anterior Corpus Callosum in Alzheimer’s Disease With Psychotic Symptoms: Cross-Sectional Magnetic Resonance Imaging Study

다국어 초록 (Multilingual Abstract)

Objective: Although previous studies have shown association between anterior corpus callosum (ACC) and various psychotic disorder, the effect of ACC on development on psychotic symptoms in Alzheimer’s disease (AD) is still unclear. The purpose of this study is to investigate the association of ACC with the development of psychosis in patients with AD.
Methods: This is a hospital based cross-sectional study of 241 AD patients. The main outcome measure is the volume of ACC that were measured as regions of interest with magnetic resonance imaging and the FreeSurfer analysis at baseline. Analysis of covariance and Logistic regression analysis conducted to assess the association between the volume of ACC and the presence of psychosis in AD, adjusting for age, education, Clinical Dementia Rating-Sum of Boxes, and total intracranial volume.
Results: We found that the volume of ACC is significantly reduced in AD with psychosis (AD+P) compared to AD without psychosis (AD-P) (774.27±142.96 vs. 833.09±142.04, p=0.005). The volume of ACC associated with the presence of psychosis in AD (odds ratio=0.995; 95% confidence interval=0.993-0.997; p=0.006).
Conclusion: We have found that reduced volume of ACC in AD+P, suggesting that ACC might play an important role in the underlying pathogenesis of development of psychotic symptoms in AD.

참고문헌 (Reference)

1 구형모 ; 김지혜 ; 권의정 ; 김성환 ; 이형석 ; 고혜정 ; 안상미 ; 김도관, "일상활동평가-복합(Seoul-Instrumental Activities of Daily Living ; S-IADL)의 신뢰도 및 타당도 연구" 대한신경정신의학회 43 (43): 189-199, 2004

2 Murray PS, "β-amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis" 33 : 2807-2816, 2012

3 Grady CL, "Subgroups in dementia of the Alzheimer type identified using positron emission tomography" 2 : 373-384, 1990

4 Goghari VM, "Smaller corpus callosum subregions containing motor fibers in schizophrenia" 73 : 59-68, 2005

5 Nakano S, "Relationship between delusions and regional cerebral blood flow in Alzheimer’s disease" 21 : 16-21, 2006

6 Jeste DV, "Psychosis of Alzheimer’s disease and related dementias. Diagnostic criteria for a distinct syndrome" 8 : 29-34, 2000

7 Murray PS, "Psychosis in Alzheimer’s disease" 75 : 542-552, 2014

8 Steele C, "Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease" 147 : 1049-1051, 1990

9 Stern Y, "Predicting time to nursing home care and death in individuals with Alzheimer disease" 277 : 806-812, 1997

10 Wragg RE, "Overview of depression and psychosis in Alzheimer’s disease" 146 : 577-587, 1989

11 Geda YE, "Neuropsychiatric symptoms in Alzheimer’s disease : past progress and anticipation of the future" 9 : 602-608, 2013

12 Rafii MS, "Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer’s disease" 29 : 159-165, 2014

13 Bruen PD, "Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease" 131 (131): 2455-2463, 2008

14 Walterfang M, "Morphology of the corpus callosum at different stages of schizophrenia : cross-sectional study in first-episode and chronic illness" 192 : 429-434, 2008

15 Brambilla P, "Magnetic resonance imaging study of corpus callosum abnormalities in patients with bipolar disorder" 54 : 1294-1297, 2003

16 Farber NB, "Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis" 57 : 1165-1173, 2000

17 Shah C, "Genetics of psychosis of Alzheimer disease" 174 : 27-35, 2017

18 Whitehead D, "Frontotemporal atrophy associated with paranoid delusions in women with Alzheimer’s disease" 24 : 99-107, 2012

19 Schneider LS, "Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease" 355 : 1525-1538, 2006

20 Ikeda M, "Delusions of Japanese patients with Alzheimer’s disease" 18 : 527-532, 2003

21 Sultzer DL, "Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer’s disease" 160 : 341-349, 2003

22 Dale AM, "Cortical surface-based analysis. I. Segmentation and surface reconstruction" 9 : 179-194, 1999

23 Walterfang M, "Corpus callosum size and shape in first-episode affective and schizophrenia-spectrum psychosis" 173 : 77-82, 2009

24 Walterfang M, "Corpus callosum size and shape in established bipolar affective disorder" 43 : 838-845, 2009

25 Bachmann S, "Corpus callosum in first-episode patients with schizophrenia--a magnetic resonance imaging study" 33 : 1019-1027, 2003

26 Atmaca M, "Corpus callosum areas in first-episode patients with bipolar disorder" 37 : 699-704, 2007

27 McKhann G, "Clinical diagnosis of Alzheimer’s disease : report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease" 34 : 939-944, 1984

28 Mega MS, "Cerebral correlates of psychotic symptoms in Alzheimer’s disease" 69 : 167-171, 2000

29 Keshavan MS, "Abnormalities of the corpus callosum in first episode, treatment naive schizophrenia" 72 : 757-760, 2002

30 Mentis MJ, "Abnormal brain glucose metabolism in the delusional misidentification syndromes : a positron emission tomography study in Alzheimer disease" 38 : 438-449, 1995

31 Kang YW, "A validity study on the Korean Mini-Mental State Examination(K-MMSE)in dementia patients" 15 : 300-308, 1997

32 Hughes CP, "A new clinical scale for the staging of dementia" 140 : 566-572, 1982